Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Tandem Diabetes Care, Inc.

https://www.tandemdiabetes.com/

Latest From Tandem Diabetes Care, Inc.

Medtronic Claims Share Gains In Cardiovascular And Neurostim

The company’s revenue was down just 1% year-over-year in the third quarter of fiscal 2021, despite the ongoing impact of the pandemic.

Sales & Earnings Business Strategies

Market Intel: Rivalry Among Insulin Pump Makers Heats Up With Expected Launches In 2021

The global insulin pump market is expected to see double-digit growth, reaching $5.1bn in 2024, with product launches expected by Medtronic, Insulet, Tandem and smaller players in 2021. 

Market Intelligence Diabetic Care

FDA Approves Medtronic’s Bluetooth-Enabled Insulin Pump For Children Ages 2 To 6

The US FDA approval of Medtronic’s Bluetooth-enabled MiniMed 770G in children as young as 2 paves the way for a PMA supplement of the next-gen MiniMed 780G.

Approvals Diabetic Care

Insulin Pump Market Heats Up Among Rivals Medtronic, Insulet and Tandem

Three major insulin pump developers are gearing up to introduce next-generation devices over the coming year, but COVID-19 continues to create uncertainties.

Diabetic Care Financing
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Drug Delivery
  • Medical Devices
    • Monitoring Equipment & Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • In Vitro Diagnostics
    • Glucose Testing
UsernamePublicRestriction

Register